Search | VHL Search Portal

1.

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.

Jun, Tomi; Hahn, Noah M; Sonpavde, Guru; Albany, Constantine; MacVicar, Gary R; Hauke, Ralph; Fleming, Mark; Gourdin, Theodore; Jana, Bagi; Oh, William K; Taik, Patricia; Wang, Huan; Varadarajan, Ajay Ramakrishnan; Uzilov, Andrew; Galsky, Matthew D.

Oncologist ; 27(6): 432-e452, 2022 06 08.

Article in English | MEDLINE | ID: mdl-35438782

2.

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.

Hussain, Maha; Daignault, Stephanie; Agarwal, Neeraj; Grivas, Petros D; Siefker-Radtke, Arlene O; Puzanov, Igor; MacVicar, Gary R; Levine, Ellis Glenn; Srinivas, Sandy; Twardowski, Przemyslaw; Eisenberger, Mario A; Quinn, David I; Vaishampayan, Ulka N; Yu, Evan Y; Dawsey, Scott; Day, Kathleen C; Day, Mark L; Al-Hawary, Mahmoud; Smith, David C.

Cancer ; 120(17): 2684-93, 2014 Sep 01.

Article in English | MEDLINE | ID: mdl-24802654

3.

Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer.

MacVicar, Gary R; Hussain, Maha H.

Curr Opin Oncol ; 25(3): 252-60, 2013 May.

Article in English | MEDLINE | ID: mdl-23511665

4.

Prostate cancer, version 1.2014.

Mohler, James L; Kantoff, Philip W; Armstrong, Andrew J; Bahnson, Robert R; Cohen, Michael; D'Amico, Anthony Victor; Eastham, James A; Enke, Charles A; Farrington, Thomas A; Higano, Celestia S; Horwitz, Eric Mark; Kawachi, Mark H; Kuettel, Michael; Lee, Richard J; Macvicar, Gary R; Malcolm, Arnold W; Miller, David; Plimack, Elizabeth R; Pow-Sang, Julio M; Richey, Sylvia; Roach, Mack; Rohren, Eric; Rosenfeld, Stan; Small, Eric J; Srinivas, Sandy; Stein, Cy; Strope, Seth A; Tward, Jonathan; Walsh, Patrick C; Shead, Dorothy A; Ho, Maria.

J Natl Compr Canc Netw ; 11(12): 1471-9, 2013 Dec 01.

Article in English | MEDLINE | ID: mdl-24335682

5.

Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).

Flaig, Thomas W; Tangen, Catherine M; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M Scott; McConkey, David James; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I; Bangs, Rick; MacVicar, Gary R; Bastos, Bruno R; Fowles, Jared S; Gustafson, Daniel L; Plets, Melissa; Thompson, Ian M; Lerner, Seth P.

Eur Urol ; 84(3): 341-347, 2023 09.

Article in English | MEDLINE | ID: mdl-37414705

6.

Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.

Carthon, Bradley C; Kim, Se Eun; McDermott, David F; Dutcher, Janice P; Puligandla, Maneka; Manola, Judith; Pins, Michael; Carducci, Michael A; Plimack, Elizabeth R; Appleman, Leonard J; MacVicar, Gary R; Kohli, Manish; Kuzel, Timothy M; DiPaola, Robert S; Haas, Naomi B.

Clin Genitourin Cancer ; 21(5): 546-554, 2023 10.

Article in English | MEDLINE | ID: mdl-37455214

7.

Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

Mohler, James L; Armstrong, Andrew J; Bahnson, Robert R; Boston, Barry; Busby, J Erik; D'Amico, Anthony Victor; Eastham, James A; Enke, Charles A; Farrington, Thomas; Higano, Celestia S; Horwitz, Eric Mark; Kantoff, Philip W; Kawachi, Mark H; Kuettel, Michael; Lee, Richard J; MacVicar, Gary R; Malcolm, Arnold W; Miller, David; Plimack, Elizabeth R; Pow-Sang, Julio M; Roach, Mack; Rohren, Eric; Rosenfeld, Stan; Srinivas, Sandy; Strope, Seth A; Tward, Jonathan; Twardowski, Przemyslaw; Walsh, Patrick C; Ho, Maria; Shead, Dorothy A.

J Natl Compr Canc Netw ; 10(9): 1081-7, 2012 Sep.

Article in English | MEDLINE | ID: mdl-22956807

8.

A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695).

Flaig, Thomas W; Tangen, Catherine M; Daneshmand, Siamak; Alva, Ajjai; Lerner, Seth P; Lucia, M Scott; McConkey, David J; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I; Bangs, Rick; MacVicar, Gary R; Bastos, Bruno R; Fowles, Jared S; Gustafson, Daniel L; Plets, Melissa; Thompson, Ian M.

Clin Cancer Res ; 27(9): 2435-2441, 2021 05 01.

Article in English | MEDLINE | ID: mdl-33568346

9.

Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216).

Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Morrison, Gareth J; Cunha, Alexander; Xu, Tong; Pinski, Jacek K; Ingles, Sue A; Triche, Timothy; Harzstark, Andrea L; Kohli, Manish; MacVicar, Gary R; Vaena, Daniel A; Crispino, Anthony W; McConkey, David J; Lara, Primo N; Hussain, Maha H A; Quinn, David I; Vogelzang, Nicholas J; Thompson, Ian Murchie; Agarwal, Neeraj.

Clin Cancer Res ; 27(7): 1967-1973, 2021 04 01.

Article in English | MEDLINE | ID: mdl-33500355

10.

Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.

Shah, Rajal B; Mehra, Rohit; Chinnaiyan, Arul M; Shen, Ronglai; Ghosh, Debashis; Zhou, Ming; Macvicar, Gary R; Varambally, Soorynarayana; Harwood, Jason; Bismar, Tarek A; Kim, Robert; Rubin, Mark A; Pienta, Kenneth J.

Cancer Res ; 64(24): 9209-16, 2004 Dec 15.

Article in English | MEDLINE | ID: mdl-15604294

11.

Chemotherapy for prostate cancer: implementing early systemic therapy to improve outcomes.

Macvicar, Gary R; Hussain, Maha.

Cancer Chemother Pharmacol ; 56 Suppl 1: 69-77, 2005 Nov.

Article in English | MEDLINE | ID: mdl-16273364

12.

Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer.

Dreicer, Robert; MacLean, David; Suri, Ajit; Stadler, Walter M; Shevrin, Daniel; Hart, Lowell; MacVicar, Gary R; Hamid, Omid; Hainsworth, John; Gross, Mitchell E; Shi, Yuanjun; Webb, Iain J; Agus, David B.

Clin Cancer Res ; 20(5): 1335-44, 2014 Mar 01.

Article in English | MEDLINE | ID: mdl-24418642

13.

Using intensity-modulated radiotherapy to spare the kidney in a patient with seminoma and a solitary kidney: a case report.

Choi, Mehee; Hayes, John P; Mehta, Minesh P; Swisher, Andrew; Small, William; Mittal, Bharat B; MacVicar, Gary R; Kalapurakal, John A; Sejpal, Samir V.

Tumori ; 99(2): e38-42, 2013.

Article in English | MEDLINE | ID: mdl-23748827

14.

Predictors of response to targeted therapy in renal cell carcinoma.

Eisengart, Laurie J; MacVicar, Gary R; Yang, Ximing J.

Arch Pathol Lab Med ; 136(5): 490-5, 2012 May.

Article in English | MEDLINE | ID: mdl-22229848

15.

Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.

Hussain, Maha H A; MacVicar, Gary R; Petrylak, Daniel P; Dunn, Rodney L; Vaishampayan, Ulka; Lara, Primo N; Chatta, Gurkamal S; Nanus, David M; Glode, L Michael; Trump, Donald L; Chen, Helen; Smith, David C.

J Clin Oncol ; 25(16): 2218-24, 2007 Jun 01.

Article in English | MEDLINE | ID: mdl-17538166

16.

Testicular cancer.

MacVicar, Gary R; Pienta, Kenneth J.

Curr Opin Oncol ; 16(3): 253-6, 2004 May.

Article in English | MEDLINE | ID: mdl-15069322

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: